164 related articles for article (PubMed ID: 33941101)
1. A 17 year experience of attrition from care among HIV infected children in Nnewi South-East Nigeria.
Onubogu CU; Ugochukwu EF
BMC Infect Dis; 2021 May; 21(1):409. PubMed ID: 33941101
[TBL] [Abstract][Full Text] [Related]
2. Attrition among HIV positive children enrolled under integrated HIV care programme in Myanmar: 12 years cohort analysis.
Minn AC; Kyaw NTT; Aung TK; Mon OM; Htun T; Oo MM; Moe J; Mon AA; Satyanarayana S; Oo HN
Glob Health Action; 2018; 11(1):1510593. PubMed ID: 30191749
[TBL] [Abstract][Full Text] [Related]
3. Predictors of loss to follow-up among children in the first and second years of antiretroviral treatment in Johannesburg, South Africa.
Sengayi M; Dwane N; Marinda E; Sipambo N; Fairlie L; Moultrie H
Glob Health Action; 2013 Jan; 6():19248. PubMed ID: 23364098
[TBL] [Abstract][Full Text] [Related]
4. Pediatric HIV care and treatment services in Tanzania: implications for survival.
Somi G; Majigo M; Manyahi J; Nondi J; Agricola J; Sambu V; Todd J; Rwebembera A; Makyao N; Ramadhani A; Matee M
BMC Health Serv Res; 2017 Aug; 17(1):540. PubMed ID: 28784131
[TBL] [Abstract][Full Text] [Related]
5. Association of adherence support and outreach services with total attrition, loss to follow-up, and death among ART patients in sub-Saharan Africa.
Lamb MR; El-Sadr WM; Geng E; Nash D
PLoS One; 2012; 7(6):e38443. PubMed ID: 22685569
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and early clinical outcomes of key populations attending comprehensive community-based HIV care: Experiences from Nasarawa State, Nigeria.
Ibiloye O; Decroo T; Eyona N; Eze P; Agada P
PLoS One; 2018; 13(12):e0209477. PubMed ID: 30571744
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India.
Alvarez-Uria G; Naik PK; Pakam R; Midde M
Glob Health Action; 2013 Sep; 6():21682. PubMed ID: 24028937
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of Nigeria's HIV/AIDS Treatment Program for Patients Initiated on Antiretroviral Treatment between 2004-2012.
Dalhatu I; Onotu D; Odafe S; Abiri O; Debem H; Agolory S; Shiraishi RW; Auld AF; Swaminathan M; Dokubo K; Ngige E; Asadu C; Abatta E; Ellerbrock TV
PLoS One; 2016; 11(11):e0165528. PubMed ID: 27829033
[TBL] [Abstract][Full Text] [Related]
9. Temporal trends in mortality and loss to follow-up among children enrolled in Côte d'Ivoire's national antiretroviral therapy program.
Auld AF; Tuho MZ; Ekra KA; Shiraishi RW; Mohamed F; Kouakou JS; Ettiègne-Traoré V; Sabatier J; Essombo J; Rivadeneira ED; Adjorlolo-Johnson G; Marlink R; Ellerbrock TV
Pediatr Infect Dis J; 2014 Nov; 33(11):1134-40. PubMed ID: 25093975
[TBL] [Abstract][Full Text] [Related]
10. Attrition in HIV care following HIV diagnosis: a comparison of the pre-UTT and UTT eras in South Africa.
Onoya D; Hendrickson C; Sineke T; Maskew M; Long L; Bor J; Fox MP
J Int AIDS Soc; 2021 Feb; 24(2):e25652. PubMed ID: 33605061
[TBL] [Abstract][Full Text] [Related]
11. High loss to follow-up of children on antiretroviral treatment in a primary care HIV clinic in Johannesburg, South Africa.
Chandiwana N; Sawry S; Chersich M; Kachingwe E; Makhathini B; Fairlie L
Medicine (Baltimore); 2018 Jul; 97(29):e10901. PubMed ID: 30024494
[TBL] [Abstract][Full Text] [Related]
12. Low risk of death, but substantial program attrition, in pediatric HIV treatment cohorts in Sub-Saharan Africa.
KIDS-ART-LINC Collaboration
J Acquir Immune Defic Syndr; 2008 Dec; 49(5):523-31. PubMed ID: 18989227
[TBL] [Abstract][Full Text] [Related]
13. Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study.
Desmonde S; Tanser F; Vreeman R; Takassi E; Edmonds A; Lumbiganon P; Pinto J; Malateste K; McGowan C; Kariminia A; Yotebieng M; Dicko F; Yiannoutsos C; Mubiana-Mbewe M; Wools-Kaloustian K; Davies MA; Leroy V;
PLoS Med; 2018 May; 15(5):e1002565. PubMed ID: 29727458
[TBL] [Abstract][Full Text] [Related]
14. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
[TBL] [Abstract][Full Text] [Related]
15. Validity of reported retention in antiretroviral therapy after roll-out to peripheral facilities in Mozambique: Results of a retrospective national cohort analysis.
Lafort Y; Couto A; Sunderbrink U; Hoek R; Shargie E; Zhao J; Viisainen K; Simwaka B
PLoS One; 2018; 13(6):e0198916. PubMed ID: 29927961
[TBL] [Abstract][Full Text] [Related]
16. Attrition of HIV-positive children from HIV services in low and middle-income countries.
Carlucci JG; Liu Y; Clouse K; Vermund SH
AIDS; 2019 Dec; 33(15):2375-2386. PubMed ID: 31764102
[TBL] [Abstract][Full Text] [Related]
17. Equity of child and adolescent treatment, continuity of care and mortality, according to age and gender among enrollees in a large HIV programme in Tanzania.
Chaudhury S; Hertzmark E; Muya A; Sando D; Ulenga N; Machumi L; Spiegelman D; Fawzi WW
J Int AIDS Soc; 2018 Feb; 21 Suppl 1(Suppl Suppl 1):. PubMed ID: 29485735
[TBL] [Abstract][Full Text] [Related]
18. Rates and predictors of attrition among children on antiretroviral therapy in Ethiopia: A prospective cohort study.
Biru M; Hallström I; Lundqvist P; Jerene D
PLoS One; 2018; 13(2):e0189777. PubMed ID: 29408897
[TBL] [Abstract][Full Text] [Related]
19. Predictors of loss to follow-up among children attending HIV clinic in a hospital in rural Kenya.
Saumu WM; Maleche-Obimbo E; Irimu G; Kumar R; Gichuhi C; Karau B
Pan Afr Med J; 2019; 32():216. PubMed ID: 31312327
[TBL] [Abstract][Full Text] [Related]
20. High attrition among HIV-infected patients with advanced disease treated in an intermediary referral center in Maputo, Mozambique.
Molfino L; Kumar AM; Isaakidis P; Van den Bergh R; Khogali M; Hinderaker SG; Magaia A; Lobo S; Edwards CG; Walter J
Glob Health Action; 2014; 7():23758. PubMed ID: 24717189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
